RecallDepth
Class II Terminated

GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21

Company
Amerisource Health Services
Recall Initiated
February 3, 2017
Posted
March 22, 2017
Recall Number
D-0520-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
19,393 cartons (581,790 extended release tablets)
Firm Location
Columbus, OH, United States

Reason for Recall

Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

Distribution

Nationwide

Lot / Code Info

Lot #160133, 160549 Exp. 08/17 Lot #162006; Exp. 09/17 Lot #163348A, 163348B; Exp. 10/17

More recalls by Amerisource Health Services

View all recalls by this company →

Other recent Class II Drug recalls